The Science and Research team at Critical Path Institute (C-Path) drives scientific and regulatory innovations by leveraging deep expertise in data science, clinical outcome assessment, modeling and simulation, and patient-reported outcomes. This highly specialized team collaborates with stakeholders across academia, regulatory bodies, and the pharmaceutical industry to develop and implement new methodologies that enhance medical research and accelerate drug development.
Cheryl Coon
Vice President, Clinical Outco...
Cole Ayasse
Clinical Outcome Assessment Sc...
Graham Marsh
Scientific Director
Heidi Grabenstatter
Scientific Director, Rdca-dap
Huong Huynh Reagan
Director Of Regulatory Science
Maria Mattera
Senior Scientific Director, Pa...
Martijn Muller
Senior Scientific Director
Ramona Walls
Executive Director Of Data Sci...
Shu Chin
VP Of MIDD & Quantitative Medi...
Smith Heavner Ph.D.,...
Senior Scientific Director
Stacy Coe
Senior Clinical Research Coord...
View all